Excessive activation of the MYC gene by amplification can be observed in breast, pancreatic or lung cancer, while its aberrant influence on signaling pathways such as PI3K/AKT or MAPK is typical of glioblastoma and colon cancer [117]. This evidence concerns the gene MYC and lung cancer.